Affects 37.3 million Americans

GLP-1 Weight Loss for Type 2 Diabetes

Type 2 diabetes affects over 37 million Americans and is closely linked to excess body weight -- approximately 85-90% of people with type 2 diabetes are overweight or obese. The condition creates a vicious cycle: insulin resistance leads to weight gain, and excess weight worsens insulin resistance. Managing blood sugar while simultaneously losing weight has historically been one of the greatest challenges for people with type 2 diabetes. Many traditional diabetes medications actually promote weight gain, making the problem even harder to solve.

GLP-1 treatment for patients with Type 2 Diabetes. Prescribed by licensed providers, delivered to your door. Compounded medications are not FDA-approved.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Type 2 Diabetes is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated June 2026Medically reviewed by licensed providers

Semaglutide and tirzepatide are the active ingredients in FDA-approved GLP-1 medications (Wegovy®, Zepbound®) whose clinical trials of the FDA-approved brand-name products studied populations that included patients with Type 2 Diabetes. Type 2 Diabetes affects approximately Affects 37.3 million Americans of U.S. adults. Weight Method offers compounded programs starting at $199/month with virtual consultations and direct shipping. Compounded medications are not FDA-approved.

How do GLP-1 medications help with this condition?

GLP-1 receptor agonists were originally developed as diabetes medications, so they uniquely address both blood sugar control and weight loss simultaneously. Semaglutide and tirzepatide stimulate insulin release only when blood sugar is elevated, reducing the risk of hypoglycemia. They also slow gastric emptying and reduce appetite, leading to significant caloric reduction. Clinical trials show that patients with type 2 diabetes lose 12-18% of body weight on these medications while achieving substantial improvements in HbA1c levels, often reducing or eliminating the need for other diabetes drugs.

Who qualifies for treatment?

If you have type 2 diabetes and a BMI of 27 or higher, you are a strong candidate for GLP-1 therapy. The combination of diabetes and excess weight is one of the primary indications for these medications. Weight Method provides comprehensive medical evaluation to ensure safe treatment alongside your existing diabetes management plan.

Ready to Get Started?

Answer a few quick questions to see if you qualify for GLP-1 medication.

Check Eligibility

How It Works

1

Take the Quiz

Answer questions about your health and medical condition.

2

Virtual Consultation

A provider will review your case and create a personalized plan.

3

Get Your Medication

Your GLP-1 medication ships directly to your door.

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

In some cases, yes. Many patients are able to reduce or discontinue other diabetes medications after starting GLP-1 therapy, as both blood sugar and weight improve. However, any medication changes should be made under the guidance of your healthcare provider.

GLP-1 medications have a low risk of hypoglycemia because they stimulate insulin in a glucose-dependent manner -- meaning they only increase insulin when blood sugar is elevated. However, if combined with insulin or sulfonylureas, the risk increases and doses may need adjustment.

Even a 5-10% reduction in body weight can significantly improve insulin sensitivity and blood sugar control. Many patients see their HbA1c drop by 1-2 percentage points, and some achieve levels that no longer meet the diagnostic criteria for diabetes.

Both are highly effective. Tirzepatide has shown slightly greater weight loss and HbA1c reduction in head-to-head trials due to its dual GLP-1/GIP mechanism. Your Weight Method provider will recommend the best fit based on your A1c levels, weight goals, and overall health.

Weight Method's program offers compounded semaglutide at $154/month and compounded tirzepatide at $329/month, with no insurance required. The monthly price covers the medication, the licensed-provider evaluation, ongoing provider access, dose management, and home shipping. Compounded semaglutide and compounded tirzepatide are not FDA-approved.

Yes. Beyond blood sugar and weight management, GLP-1 medications have shown cardiovascular benefits, reducing the risk of heart attack, stroke, and kidney disease -- all common complications of type 2 diabetes.

Start Your Treatment

Find out if GLP-1 medications can help you lose weight with Type 2 Diabetes.

Get Started Now

Free consultation. No commitment.

GLP-1 Medications

SemaglutideTirzepatideSemaglutide vs Tirzepatide

Other Conditions

PCOSHypothyroidismSleep ApneaHigh Blood PressureJoint Pain & ArthritisMetabolic SyndromePrediabetes

Type 2 Diabetes by City

Type 2 Diabetes in Abbeville, LAType 2 Diabetes in Aberdeen, MDType 2 Diabetes in Aberdeen, SDType 2 Diabetes in Aberdeen, WAType 2 Diabetes in Abilene, TXType 2 Diabetes in Acworth, GAType 2 Diabetes in Ada, OKType 2 Diabetes in Addison, IL